Teva Pharmaceuticals USA Inc.has announced the launch of “the first and only digital rescue inhaler,” its ProAir Digihaler (albuterol sulfate), which received approval from the US Food and Drug Administration in December 2018.
Commenting on the launch, Brendan O’Grady, executive vice president of North America commercial at Teva, said, “The launch of ProAir...




